Keyphrases
Metastatic Melanoma
100%
Melanoma Cells
100%
Brain Metastases
100%
Renal Cancer
100%
Craniotomy
100%
Interleukin-2
83%
Resection
50%
Surgical Treatment
50%
Disease-free Interval
50%
Complete Response
33%
Partial Response
33%
Multiple Metastases
33%
Brain Development
33%
Neurologic Symptoms
16%
After Surgery
16%
Retrospective Analysis
16%
Overall Survival
16%
Clinical Response
16%
National Cancer Institute
16%
Median Survival
16%
Patient Selection
16%
No Response
16%
Disease-free
16%
Complete Resolution
16%
Palliation
16%
Site of Disease
16%
Extracranial
16%
Medicine and Dentistry
Disease
100%
Surgery
100%
Immunotherapy
100%
Cancer Cell
100%
Metastatic Melanoma
100%
Brain Metastasis
100%
Craniotomy
100%
Interleukin 2
83%
Metastatic Carcinoma
33%
Symptom
33%
Malignant Neoplasm
16%
Symptomatic Treatment
16%
Neurologic Disease
16%
Overall Survival
16%
Neuroscience
Immunotherapy
100%
Interleukin 2
100%
Craniotomy
100%